Van Ganse E - Search Results

1

Risk of relapse after natalizumab withdrawal: Results from the French TYSEDMUS cohort.

Papeix C, Vukusic S, Casey R, Debard N, Stankoff B, Mrejen S, Uhry Z, Van Ganse E, Castot A, Clanet M, Lubetzki C, Confavreux C; TYSEDMUS and OFSEP Group. Papeix C, et al. Among authors: van ganse e. Neurol Neuroimmunol Neuroinflamm. 2016 Oct 28;3(6):e297. doi: 10.1212/NXI.0000000000000297. eCollection 2016 Dec. Neurol Neuroimmunol Neuroinflamm. 2016. PMID: 27844037 Free PMC article.

2

Influence of lansoprazole treatment on diazepam plasma concentrations.

Lefebvre RA, Flouvat B, Karolac-Tamisier S, Moerman E, Van Ganse E. Lefebvre RA, et al. Among authors: van ganse e. Clin Pharmacol Ther. 1992 Nov;52(5):458-63. doi: 10.1038/clpt.1992.172. Clin Pharmacol Ther. 1992. PMID: 1424419 Clinical Trial.

3

Na+-H+ exchange in the process of glucose-induced insulin release from the pancreatic B-cell. Effects of amiloride on 86Rb, 45Ca fluxes and insulin release.

Lebrun P, van Ganse E, Juvent M, Deleers M, Herchuelz A. Lebrun P, et al. Among authors: van ganse e. Biochim Biophys Acta. 1986 May 29;886(3):448-56. doi: 10.1016/0167-4889(86)90181-3. Biochim Biophys Acta. 1986. PMID: 2423136

4

[Use of databases in pharmacovigilance: two examples].

Van Ganse E. Van Ganse E. Therapie. 1995 Sep-Oct;50(5):409-12. Therapie. 1995. PMID: 8571277 French.

5

Failure of indomethacin to impair the diuretic and natriuretic effects of the loop diuretic torasemide in healthy volunteers.

van Ganse E, Douchamps J, Deger F, Staroukine M, Verniory A, Herchuelz A. van Ganse E, et al. Eur J Clin Pharmacol. 1986;31 Suppl:43-7. doi: 10.1007/BF00541466. Eur J Clin Pharmacol. 1986. PMID: 3536531

6

Cost-effectiveness of pravastatin in secondary prevention of coronary heart disease: comparison between Belgium and the United States of a projected risk model.

Muls E, Van Ganse E, Closon MC. Muls E, et al. Among authors: van ganse e. Atherosclerosis. 1998 Apr;137 Suppl:S111-6. doi: 10.1016/s0021-9150(97)00321-3. Atherosclerosis. 1998. PMID: 9694550 Clinical Trial.

7

Challenges and Opportunities With Routinely Collected Data on the Utilization of Cancer Medicines. Perspectives From Health Authority Personnel Across 18 European Countries.

Pisana A, Wettermark B, Kurdi A, Tubic B, Pontes C, Zara C, Van Ganse E, Petrova G, Mardare I, Fürst J, Roig-Izquierdo M, Melien O, Bonanno PV, Banzi R, Marković-Peković V, Mitkova Z, Godman B. Pisana A, et al. Among authors: van ganse e. Front Pharmacol. 2022 Jun 16;13:873556. doi: 10.3389/fphar.2022.873556. eCollection 2022. Front Pharmacol. 2022. PMID: 35865969 Free PMC article.

8

Interaction between nonsteroidal anti-inflammatory drugs and loop diuretics: modulation by sodium balance.

Herchuelz A, Derenne F, Deger F, Juvent M, Van Ganse E, Staroukine M, Verniory A, Boeynaems JM, Douchamps J. Herchuelz A, et al. Among authors: van ganse e. J Pharmacol Exp Ther. 1989 Mar;248(3):1175-81. J Pharmacol Exp Ther. 1989. PMID: 2703968

9

Anti-osteoporotic treatments in France: initiation, persistence and switches over 6 years of follow-up.

Belhassen M, Confavreux CB, Cortet B, Lamezec L, Ginoux M, Van Ganse E. Belhassen M, et al. Among authors: van ganse e. Osteoporos Int. 2017 Mar;28(3):853-862. doi: 10.1007/s00198-016-3789-y. Epub 2016 Oct 20. Osteoporos Int. 2017. PMID: 27766368

10

Mixed dyslipidemias in primary care patients in France.

Laforest L, Ambegaonkar BM, Souchet T, Sazonov V, Van Ganse E. Laforest L, et al. Among authors: van ganse e. Vasc Health Risk Manag. 2012;8:247-54. doi: 10.2147/VHRM.S27668. Epub 2012 Apr 19. Vasc Health Risk Manag. 2012. PMID: 22566746 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

178 results

Search Page

Filters